HTA is multi-disciplinary field of policy analysis that examines the medical, economic, social and ethical implications of the incremental value, diffusion and use of a health technology in health care.
The term Health Technology refers to application of organised knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of life.
Cardiovascular disease is a major public health issue accounting for almost 17 million deaths per year globally. According to estimates, 40-50% of them are sudden cardiac deaths. Approximately 6 million sudden cardiac deaths are caused by ventricular tachyarrhythmias. Several underlying acquired or congenital cardiac conditions are associated with an increased risk of ven-tricular arrhythmias. The implantable […]
People suffering from certain types of heart failure, or an abnormal heart rate or rhythm, may have one ofseveral electronic devices implanted (e.g., a defibrillator or a pacemaker). However, patients require routine follow up in-clinic for clinical assessment and to verify that the device is functioning properly, which can be a burden for those who have difficulty traveling […]
Aims and Scope The first research question submitted to KCE concerned the clinical- and cost-effectiveness of the provision of publicly accessible automated external defibrillators (AED) intended for opportunistic use by bystanders who witness a cardiac arrest. The report focuses on the use of AEDs as a standalone intervention, i.e. not incorporated into a coordinated public access defibrillation (PAD) programme (see section […]
The report focuses on the use of AEDs as a standalone intervention, i.e. not incorporated into a coordinated public access defibrillation (PAD) programme, because this is currently the dominant practice in Belgium. The question was not to advise the government about the most effective strategies for PAD, as the governmental involvement in PAD is very limited, but if it should support (also […]
On 25 July 2013, the then Minister for Health, Dr James Reilly, requested that the Health Information and Quality Authority undertake a health technology assessment (HTA) of a public access defibrillation programme. This was with the aim of informing decision-making on matters related to the Public Health (Availability of Defibrillators) Bill 2013. The Bill lists the […]
In Italy, cardiovascular disease is a leading cause of mortality, morbidity, and disability. Among all cardiovascular diseases, a prominent role is played by heart failure (HF), with 600,000 people suffering from heart failure. It is estimated that the frequency of this condition will double with each decade of age. The limited cardiac reserve of HF patients […]
Implantable cardioverter–defibrillators (ICDs) are battery-powered implantable devices that monitor heart rhythm and deliver therapy in the form of either electric shock or antitachycardia pacing (ATP) when a life-threatening ventricular arrhythmia is detected. ICDs have been used in patients who survived sustained ventricular arrhythmias to prevent sudden cardiac death (SCD). In recent years, ICDs have also been […]
The objective of this Medical Advisory Secretariat (MAS) report was to conduct a systematic review of the available published evidence on the safety, effectiveness, and cost-effectiveness of Internet-based device-assisted remote monitoring systems (RMSs) for therapeutic cardiac implantable electronic devices (CIEDs) such as pacemakers (PMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. The MAS evidence-based review was performed to […]
Sudden cardiac death (SCD) is defined as a natural death due to cardiac causes, heralded by an abrupt loss of consciousness within one hour of the onset of acute symptoms. It is mostly initiated by a sudden inappropriate and extreme increase in heart rate (typically more than 200/min), eventually leading to a mechanical arrest of the […]
The objectives were to identify the components of a program to deliver early defibrillation that optimizes the effectiveness of automated external defibrillators (AEDs) in out-of-hospital and hospital settings, to determine whether AEDs are cost-effective, and if cost-effectiveness was determined, to advise on how they should be distributed in Ontario. An AED is a device that can analyze a heart […]